• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chronic refractory angina pectoris: recent progress and remaining challenges.

作者信息

Waltenberger Johannes

机构信息

Department of Cardiovascular Medicine, Division of Cardiology, University Hospital Münster, Münster, Germany.

Cells-in-Motion Cluster of Excellence, EXC 1003-CiM, University of Münster, Münster, Germany.

出版信息

Eur Heart J. 2017 Sep 1;38(33):2556-2558. doi: 10.1093/eurheartj/ehx421.

DOI:10.1093/eurheartj/ehx421
PMID:28903477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5837796/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/5837796/03c7b0449457/ehx421f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/5837796/03c7b0449457/ehx421f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/5837796/03c7b0449457/ehx421f1.jpg

相似文献

1
Chronic refractory angina pectoris: recent progress and remaining challenges.慢性难治性心绞痛：近期进展与尚存挑战
Eur Heart J. 2017 Sep 1;38(33):2556-2558. doi: 10.1093/eurheartj/ehx421.
2
Usefulness of Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina Pectoris.经冠状窦减少器植入术治疗慢性难治性心绞痛的效果。
Am J Cardiol. 2021 Jan 15;139:22-27. doi: 10.1016/j.amjcard.2020.09.045. Epub 2020 Sep 28.
3
Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris.雷诺嗪对难治性心绞痛患者临床结局和医疗资源利用的影响。
Am J Cardiovasc Drugs. 2013 Dec;13(6):407-12. doi: 10.1007/s40256-013-0038-z.
4
Refractory angina pectoris carries a favourable prognosis: a three-year follow-up of 150 patients.难治性心绞痛预后良好：150例患者的三年随访
Scand Cardiovasc J. 2008 Oct;42(5):291-4. doi: 10.1080/14017430802084997.
5
Intraoperative multiplane transesophageal echocardiography for guiding direct myocardial gene transfer of vascular endothelial growth factor in patients with refractory angina pectoris.术中多平面经食管超声心动图引导血管内皮生长因子对难治性心绞痛患者进行直接心肌基因转移
Hum Gene Ther. 1999 Sep 20;10(14):2307-14. doi: 10.1089/10430349950016951.
6
Occurrence of angina pectoris prior to acute myocardial infarction and its relation to prognosis.
Eur Heart J. 1993 Apr;14(4):484-91. doi: 10.1093/eurheartj/14.4.484.
7
Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up.直接心肌内间质基质细胞注射治疗严重难治性心绞痛患者：一年随访。
Cell Transplant. 2013;22(3):521-8. doi: 10.3727/096368912X636830. Epub 2012 Apr 2.
8
One year follow-up of patients with refractory angina pectoris treated with enhanced external counterpulsation.难治性心绞痛患者接受增强型体外反搏治疗的一年随访
BMC Cardiovasc Disord. 2006 Jun 15;6:28. doi: 10.1186/1471-2261-6-28.
9
External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris.体外反搏治疗可改善难治性心绞痛患者的内皮功能。
J Am Coll Cardiol. 2003 Dec 17;42(12):2090-5. doi: 10.1016/j.jacc.2003.05.013.
10
Targeting vascular endothelial growth factor in angina therapy.心绞痛治疗中靶向血管内皮生长因子
Expert Opin Ther Targets. 2006 Feb;10(1):5-14. doi: 10.1517/14728222.10.1.5.

引用本文的文献

1
Overview of systematic reviews on Chinese patented oral medicines for promoting blood circulation and removing blood stasis combined with western medicine in the treatment of coronary heart disease angina pectoris.中药活血化瘀专利口服药联合西药治疗冠心病心绞痛的系统评价概述
Front Cardiovasc Med. 2025 Jun 20;12:1553735. doi: 10.3389/fcvm.2025.1553735. eCollection 2025.
2
External Counterpulsation Improves Angiogenesis by Preserving Vascular Endothelial Growth Factor-A and Vascular Endothelial Growth Factor Receptor-2 but Not Regulating MicroRNA-92a Expression in Patients With Refractory Angina.体外反搏通过保护血管内皮生长因子-A和血管内皮生长因子受体-2而非调节难治性心绞痛患者的微小RNA-92a表达来改善血管生成。
Front Cardiovasc Med. 2021 Oct 25;8:761112. doi: 10.3389/fcvm.2021.761112. eCollection 2021.
3

本文引用的文献

1
Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up.腺病毒心肌内 VEGF-DΔNΔC 基因转移增加难治性心绞痛患者的心肌血流储备：一项 1 年随访的 I/IIa 期研究。
Eur Heart J. 2017 Sep 1;38(33):2547-2555. doi: 10.1093/eurheartj/ehx352.
2
AdVEGF-B186 and AdVEGF-DΔNΔC induce angiogenesis and increase perfusion in porcine myocardium.腺病毒载体介导的血管内皮生长因子-B186和腺病毒载体介导的血管内皮生长因子-DΔNΔC可诱导猪心肌血管生成并增加灌注。
Heart. 2016 Nov 1;102(21):1716-1720. doi: 10.1136/heartjnl-2016-309373. Epub 2016 May 12.
3
Spinal cord stimulation reduces cardiac pain through microglial deactivation in rats with chronic myocardial ischemia.脊髓刺激通过慢性心肌缺血大鼠小胶质细胞失活减轻心脏疼痛。
Mol Med Rep. 2021 Dec;24(6). doi: 10.3892/mmr.2021.12475. Epub 2021 Oct 5.
4
Study of Scraping with Copper Stone Based on Theory of Midnight-Noon Ebb-Flow in Angina Pectoris with Coronary Heart Disease of Qi Stagnation and Blood Stasis.基于子午流注理论的铜砭刮痧对冠心病气滞血瘀型心绞痛的研究
Evid Based Complement Alternat Med. 2021 Sep 18;2021:2677696. doi: 10.1155/2021/2677696. eCollection 2021.
5
Kuanxiong Aerosol () in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology.宽胸气雾剂（）治疗心绞痛：文献综述及网络药理学研究。
Chin J Integr Med. 2021 Jun;27(6):470-480. doi: 10.1007/s11655-021-2867-y. Epub 2021 May 28.
Cardiac shockwave therapy in patients with chronic refractory angina pectoris.
慢性难治性心绞痛患者的心脏冲击波疗法。
Neth Heart J. 2016 May;24(5):343-9. doi: 10.1007/s12471-016-0821-y.
4
Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview.经皮冠状动脉慢性完全闭塞病变血运重建的适宜性：综述。
Eur Heart J. 2016 Sep 14;37(35):2692-700. doi: 10.1093/eurheartj/ehv391. Epub 2015 Aug 7.
5
Enhanced External Counterpulsation Is Cost-Effective in Reducing Hospital Costs in Refractory Angina Patients.增强型体外反搏在降低难治性心绞痛患者的医院成本方面具有成本效益。
Clin Cardiol. 2015 Jun;38(6):344-9. doi: 10.1002/clc.22395. Epub 2015 May 11.
6
Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome.慢性完全闭塞病变经皮冠状动脉介入治疗对左心室功能及临床结局影响的Meta分析
Int J Cardiol. 2015;187:90-6. doi: 10.1016/j.ijcard.2015.03.164. Epub 2015 Mar 17.
7
Efficacy of a device to narrow the coronary sinus in refractory angina.一种用于缩窄冠状静脉窦治疗难治性心绞痛的装置的疗效。
N Engl J Med. 2015 Feb 5;372(6):519-27. doi: 10.1056/NEJMoa1402556.
8
Gene therapy to stimulate angiogenesis to treat diffuse coronary artery disease.基因治疗刺激血管生成治疗弥漫性冠状动脉疾病。
Hum Gene Ther. 2013 Nov;24(11):948-63. doi: 10.1089/hum.2013.2516.
9
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.2013年欧洲心脏病学会稳定型冠状动脉疾病管理指南：欧洲心脏病学会稳定型冠状动脉疾病管理特别工作组
Eur Heart J. 2013 Oct;34(38):2949-3003. doi: 10.1093/eurheartj/eht296. Epub 2013 Aug 30.
10
Modulation of growth factor action: implications for the treatment of cardiovascular diseases.生长因子作用的调节：对心血管疾病治疗的意义。
Circulation. 1997 Dec 2;96(11):4083-94. doi: 10.1161/01.cir.96.11.4083.